序号 |
标题 |
次数 |
作者 |
发布时间 |
83251 |
双功能螯合剂DOTA共轭RAWVAWR-NH2,DOTA-RAWVAWR-NH2 |
96 |
kx |
2024-11-28 |
83252 |
Lu-DOTA-TATE/Ga-DOTA-TRP 大环化合物 |
172 |
zcy |
2024-11-28 |
83253 |
偕胺肟化聚丙烯腈-β-环糊精纳米纤维膜 AOPAN-β-CD |
255 |
h |
2024-11-28 |
83254 |
cFLFLFK-MHI-DOTA, 靶向多模式探针 |
127 |
kx |
2024-11-28 |
83255 |
β-环糊精改性纤维膜 |
86 |
h |
2024-11-28 |
83256 |
EuropiuM DOTA SodiuM Salt Hydrate |
91 |
zyl |
2024-11-28 |
83257 |
CAS:753421-63-5 4-Aminobutyl-DOTA |
78 |
zyl |
2024-11-28 |
83258 |
Pteroyl-Lys-DOTA ,蝶酰-Lys-DOTA DOTA缀合的蝶酰-Lys衍生物 |
102 |
kx |
2024-11-28 |
83259 |
丙烯酸乙酯与丙烯酰胺接枝淀粉/β-环糊精树脂 EA-AM/β-CD |
92 |
h |
2024-11-28 |
83260 |
VIP-DOTA(靶向VPAC2-R) |
146 |
kx |
2024-11-28 |
83261 |
大环造影剂CAS:2126179-28-8;Ho-p-SCN-Bn-DOTA |
88 |
zyl |
2024-11-28 |
83262 |
Na[Gd(DOTA)·H2O]大环配合物 |
110 |
kx |
2024-11-28 |
83263 |
44Sc-DOTA-ZHER2:2891 , 亲和体分子ZHER2:2891偶联DOTA螯合剂 |
161 |
kx |
2024-11-28 |
83264 |
3,6-二胍基-1,2,4,5-四嗪高氯酸盐[DGTz·2(HClO4)] |
111 |
WYQ |
2024-11-28 |
83265 |
DOTA-三(酸) - 酰胺-DPEG(R)24-酰氨基-DPEG(R)24-DSPE |
86 |
zyl |
2024-11-28 |
83266 |
β-环糊精改性聚(氯甲基苯乙烯)树脂 β-CD/PS-Cl |
87 |
h |
2024-11-28 |
83267 |
3,6-二肼基-1,2,4,5-四嗪3,5-二硝基水杨酸盐二水合物(DHTz·DNSA-2H2O) |
127 |
WYQ |
2024-11-28 |
83268 |
DOTA-TOC,204318-14-9,依多曲肽 |
92 |
zcy |
2024-11-28 |
83269 |
DOTA-TRIS(TBE) - 酰胺基DPEG(R)11-马来酰亚胺 |
90 |
zyl |
2024-11-28 |
83270 |
β-环糊精改性机蒙脱七跟环氧树脂 E-44-β-CD |
154 |
h |
2024-11-28 |
83271 |
86Y-DOTA-Bn , 钇-86-DOTA-铃蟾肽 |
125 |
kx |
2024-11-28 |
83272 |
Gd-NOTA;钆-大环配体NOTA |
100 |
zcy |
2024-11-28 |
83273 |
3,6-二肼基-1,2,4,5-四嗪(DHTz) |
172 |
WYQ |
2024-11-28 |
83274 |
环糊精改性的脲醛树脂 CD-UF |
111 |
h |
2024-11-28 |
83275 |
CAS:177943-89-4 DOTATATE acetate |
150 |
zyl |
2024-11-28 |
83276 |
CAS:137076-54-1 三叔丁基1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 |
114 |
zyl |
2024-11-28 |
83277 |
3,6-双(1H-1,2,3,4-四唑-5-氨基)-1,2,4,5-四嗪(BTATz) |
92 |
WYQ |
2024-11-28 |
83278 |
3-甲基-5-芳基吡唑,3,4−e 并-1,2,3,4-四嗪衍生物 |
104 |
WYQ |
2024-11-28 |
83279 |
β-环糊精改性聚对二氧环己酮/聚乙烯醇水凝胶 β-CD-PPDO/PVA |
148 |
h |
2024-11-28 |
83280 |
DOTA-PAMAMG3.0-SH ,DOTA-PAMAMG3.0-巯基, DOTA偶联巯基化聚酰胺-胺(PAMAM)树形分子 |
111 |
kx |
2024-11-28 |
83281 |
3,3′-偶氮-1,2,4,5-四嗪衍生物 |
97 |
WYQ |
2024-11-28 |
83282 |
β-环糊精/Fe3O4/氧化石墨烯 |
112 |
h |
2024-11-28 |
83283 |
DOTA-PEG-CRGD环肽;大环配体DOTA-聚乙二醇-CRGD |
85 |
zcy |
2024-11-28 |
83284 |
3,6-二胍基-1,2,4,5-四嗪(DGTz) |
121 |
WYQ |
2024-11-28 |
83285 |
β-环糊精-聚丙烯酰胺水凝胶 β-CD-PAM |
154 |
h |
2024-11-28 |
83286 |
Iron DOTA Sodium Salt |
103 |
zyl |
2024-11-28 |
83287 |
环糊精-聚丙烯酸复合水凝胶 β-CD/PAA |
118 |
h |
2024-11-28 |
83288 |
3,6-二肼基-1,2,4,5-四嗪(DHTz) |
99 |
WYQ |
2024-11-28 |
83289 |
DOTA-c(RGDfK);具有特定生物活性的多肽分子 |
92 |
zcy |
2024-11-28 |
83290 |
1,2,3,4-四嗪-1,3-二氧化物 |
99 |
WYQ |
2024-11-28 |
83291 |
3,6-双(1H-1,2,4-三唑-3-氨基)-1,2,4,5-四嗪 |
90 |
WYQ |
2024-11-28 |
83292 |
3,6-双-(3,5-二氨基-1,2,4-三唑基)-1,2,4,5-四嗪(BTDTz) |
100 |
WYQ |
2024-11-28 |
83293 |
β-环糊精交联聚丙烯酸水凝胶 β-CD-6-A |
88 |
h |
2024-11-28 |
83294 |
DOTA-Tyr-3/temozolomide ,Dota-Tyr-3/替莫唑胺 |
87 |
kx |
2024-11-28 |
83295 |
3,6-二氯-1,2,4,5-四嗪(BCT) |
123 |
WYQ |
2024-11-28 |